Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Salinas-Alaman, A. (Ángel) | - |
dc.creator | Garcia-Layana, A. (Alfredo) | - |
dc.creator | Sanchez-Carpintero, L.M. (Luis M.) | - |
dc.creator | Belzunce, A. (Arnaldo) | - |
dc.date.accessioned | 2012-10-24T08:48:22Z | - |
dc.date.available | 2012-10-24T08:48:22Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Salinas-Alaman A, Garcia-Layana A, Sadaba-Echarri LM, Belzunce-Manterola A. Triamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retiniana. Arch Soc Esp Oftalmol 2005 Aug;80(8):463-465. | es_ES |
dc.identifier.issn | 0365-6691 | - |
dc.identifier.uri | https://hdl.handle.net/10171/23478 | - |
dc.description.abstract | Clinical cases: Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose. The remaining one case suffered a relapse three months later. Therefore a second injection was performed in that case. Discussion: Several treatments have been suggested to manage macular edema in BRVO. Intravitreal triamcinolone may be a therapeutic option to increase visual acuity and decrease macular thickness in patients with macular edema secondary to BRVO | es_ES |
dc.language.iso | spa | es_ES |
dc.publisher | Elsevier España | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Branch retinal vein occlusion | es_ES |
dc.subject | Triamcinolone | es_ES |
dc.subject | Macular edema | es_ES |
dc.title | Triamcinolona intravítrea en el tratamiento de la oclusión de rama venosa retiniana | es_ES |
dc.title.alternative | Branch retinal vein occlusion treated by intravitreal triamcinolone | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | http://dx.doi.org/10.4321/S0365-66912005000800007 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.